OMER

Omeros Corporation Healthcare - Biotechnology Investor Relations →

NO
79.0% ABOVE
↑ Moving away Was 52.8% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $5.74
14-Week RSI 47
Rel. Volume (14w) This week's trading vs. the 14-week average 1.5x
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 0.95

Omeros Corporation (OMER) closed at $10.28 as of 2026-06-19, trading 79.0% above its 200-week moving average of $5.74. The stock moved further from the line this week, up from 52.8% last week. The 14-week RSI sits at 47, indicating neutral momentum.

Trading volume is running at 1.5x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.95 ratio) is neutral — neither side is clearly dominating.

Over the past 823 weeks of data, OMER has crossed below its 200-week moving average 17 times. On average, these episodes lasted 26 weeks. Historically, investors who bought OMER at the start of these episodes saw an average one-year return of +16.5%.

With a market cap of $744 million, OMER is a small-cap stock. The company generates a free cash flow yield of 24.3%, which is notably high. The stock trades at -11.7x book value.

Share count has increased 14.1% over three years, indicating dilution.

Over the past 15.8 years, a hypothetical investment of $100 in OMER would have grown to $142, compared to $869 for the S&P 500. OMER has returned 2.2% annualized vs 14.6% for the index, underperforming the broader market over this period.

Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: OMER vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After OMER Crosses Below the Line?

Across 17 historical episodes, buying OMER when it crossed below its 200-week moving average produced an average return of +15.6% after 12 months (median -1.0%), compared to +15.0% for the S&P 500 over the same periods. 47% of those episodes were profitable after one year. After 24 months, the average return was +18.2% vs +34.1% for the index.

Each line shows $100 invested at the moment OMER crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Bean Score Experimental

The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. OMER currently has negative free cash flow, so price-based dislocation levels are not available. The score still tracks yield deviation from baseline.

Current Bean Score +0.19σ
Current FCF Yield -13.38%
Baseline Yield -12.02%
Historical σ 2.93pp

Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end

Data depth: 2 quarterly baselines, 22 price observations — Limited history (4+ quarters preferred for reliability)

Signal Accuracy Collecting Data

The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"

11 / 13 weeks minimum

Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are reference points for identifying potential swing trade opportunities, not buy/sell signals. FCF values update quarterly with earnings; between reports, all movement is price-driven.

Dislocation Scores Experimental

Each score measures deviation from OMER's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.

Yield Dislocation N/A Dividend yield vs own 10-yr norm
Drawdown Score -1.31σ Distance from line vs own history
Sector-Relative -1.12σ Vs sector median this week
Buyback Acceleration +19.0pp YoY share change vs own 3-yr pace (− = accelerating)
Insider Intensity N/A TTM buys / market cap, percentile of buyers
FCF Yield vs History +38.1pp Vs own recent annual mean
Earnings Quality Insufficient data Accrual gap trend

Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. They are starting points for research, not buy or sell signals. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.

Advertisement

Historical Touches

OMER has crossed below its 200-week MA 17 times with an average 1-year return of +16.5% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Jan 2011Jan 20125350.1%-6.7%+64.7%
Nov 2012Nov 201216.1%+23.4%+61.6%
Dec 2012Sep 20134041.2%+26.7%+57.9%
Jan 2016Mar 2016918.9%-13.5%-10.6%
May 2016Nov 20162842.3%+24.1%-17.0%
Nov 2016Mar 20171730.3%+90.1%-5.8%
Oct 2017Nov 201711.8%+9.4%-31.2%
Jan 2018Apr 20181336.1%-10.3%-32.3%
Oct 2018Oct 2018314.0%+14.7%-26.4%
Nov 2018Mar 20191731.1%+4.3%-21.0%
Jul 2019Jul 201933.7%+3.1%-30.0%
Oct 2019Oct 201910.7%-27.7%-32.9%
Nov 2019Apr 20202428.7%-23.1%-24.3%
May 2020Jan 20213537.3%+29.2%-27.0%
May 2021Sep 20211715.1%-81.1%-31.0%
Sep 2021Nov 202416388.4%-63.1%+20.4%
May 2025Oct 20252241.9%+280.4%+219.3%
Average26+16.5%

Frequently Asked Questions

Is OMER below its 200-week moving average?

No. Omeros Corporation (OMER) is currently 79.0% above its 200-week moving average of $5.74. It would need to fall to $5.74 to cross below the line.

What is OMER's 200-week moving average price?

Omeros Corporation's 200-week moving average is $5.74 as of 2026-06-19. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when OMER drops below its 200-week moving average?

OMER has crossed below its 200-week moving average 17 times in our data. On average, buying at that moment produced a one-year return of +16.5%. These dips have historically been decent entry points. These episodes lasted 26 weeks on average.

Is OMER a good value right now?

Here's what our data says about OMER as of 2026-06-19: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 47. Free cash flow yield is 24.3%. Price-to-book is -11.7x. This is not a buy or sell recommendation — always do your own research.

How does OMER compare to the S&P 500?

Over the past 15.8 years, $100 invested in OMER would have grown to $142, compared to $869 for the S&P 500. That's 2.2% annualized vs 14.6% for the index. OMER has underperformed the broader market over this period.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-06-19